113 related articles for article (PubMed ID: 36803774)
1. Elevated expression of myosin VI contributes to breast cancer progression via MAPK/ERK signaling pathway.
Zhan XJ; Wang R; Kuang XR; Zhou JY; Hu XL
Cell Signal; 2023 Jun; 106():110633. PubMed ID: 36803774
[TBL] [Abstract][Full Text] [Related]
2. MYO6 knockdown inhibits the growth and induces the apoptosis of prostate cancer cells by decreasing the phosphorylation of ERK1/2 and PRAS40.
Wang D; Zhu L; Liao M; Zeng T; Zhuo W; Yang S; Wu W
Oncol Rep; 2016 Sep; 36(3):1285-92. PubMed ID: 27431378
[TBL] [Abstract][Full Text] [Related]
3. Effect of KIF22 on promoting proliferation and migration of gastric cancer cells via MAPK-ERK pathways.
Yu ZY; Jiang XY; Zhao RR; Qin JJ; Luo CJ; Ren YX; Ren W; Ma ZJ; Jiao ZY
Chin Med J (Engl); 2020 Apr; 133(8):919-928. PubMed ID: 32187050
[TBL] [Abstract][Full Text] [Related]
4. LAGE3 promoted cell proliferation, migration, and invasion and inhibited cell apoptosis of hepatocellular carcinoma by facilitating the JNK and ERK signaling pathway.
Xing Y; Liu Y; Qi Z; Liu Z; Wang X; Zhang H
Cell Mol Biol Lett; 2021 Nov; 26(1):49. PubMed ID: 34837962
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of microRNA-190 inhibits migration, invasion, epithelial-mesenchymal transition, and angiogenesis through suppression of protein kinase B-extracellular signal-regulated kinase signaling pathway via binding to stanniocalicin 2 in breast cancer.
Sun G; Liu M; Han H
J Cell Physiol; 2019 Aug; 234(10):17824-17838. PubMed ID: 30993707
[TBL] [Abstract][Full Text] [Related]
6. ADAMTS6 suppresses tumor progression via the ERK signaling pathway and serves as a prognostic marker in human breast cancer.
Xie Y; Gou Q; Xie K; Wang Z; Wang Y; Zheng H
Oncotarget; 2016 Sep; 7(38):61273-61283. PubMed ID: 27542224
[TBL] [Abstract][Full Text] [Related]
7. CircDNAJC11 interacts with TAF15 to promote breast cancer progression via enhancing MAPK6 expression and activating the MAPK signaling pathway.
Wang B; Chen H; Deng Y; Chen H; Xing L; Guo Y; Wang M; Chen J
J Transl Med; 2023 Mar; 21(1):186. PubMed ID: 36895010
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of myosin VI regulates gastric cancer cell progression.
Wang Z; Ying M; Wu Q; Wang R; Li Y
Gene; 2016 Nov; 593(1):100-109. PubMed ID: 27515005
[TBL] [Abstract][Full Text] [Related]
9. Lentivirus-Mediated Silencing of Myosin VI Inhibits Proliferation and Cell Cycle Progression in Human Lung Cancer Cells.
Yu H; Zhu Z; Chang J; Wang J; Shen X
Chem Biol Drug Des; 2015 Oct; 86(4):606-13. PubMed ID: 25643992
[TBL] [Abstract][Full Text] [Related]
10. NCAPH promotes cell proliferation and inhibits cell apoptosis of bladder cancer cells through MEK/ERK signaling pathway.
Li B; Xiao Q; Shan L; Song Y
Cell Cycle; 2022 Feb; 21(4):427-438. PubMed ID: 34974790
[TBL] [Abstract][Full Text] [Related]
11. E26 transformation (ETS)‑specific related transcription factor‑3 (ELF3) orchestrates a positive feedback loop that constitutively activates the MAPK/Erk pathway to drive thyroid cancer.
Chen H; Chen W; Zhang X; Hu L; Tang G; Kong J; Wang Z
Oncol Rep; 2019 Jan; 41(1):570-578. PubMed ID: 30365150
[TBL] [Abstract][Full Text] [Related]
12. miR-665 expression predicts poor survival and promotes tumor metastasis by targeting NR4A3 in breast cancer.
Zhao XG; Hu JY; Tang J; Yi W; Zhang MY; Deng R; Mai SJ; Weng NQ; Wang RQ; Liu J; Zhang HZ; He JH; Wang HY
Cell Death Dis; 2019 Jun; 10(7):479. PubMed ID: 31209222
[TBL] [Abstract][Full Text] [Related]
13. Reduced miR-550a-3p leads to breast cancer initiation, growth, and metastasis by increasing levels of ERK1 and 2.
Ho JY; Hsu RJ; Wu CH; Liao GS; Gao HW; Wang TH; Yu CP
Oncotarget; 2016 Aug; 7(33):53853-53868. PubMed ID: 27462780
[TBL] [Abstract][Full Text] [Related]
14. LncRNA ST8SIA6-AS1 promotes proliferation, migration and invasion in breast cancer through the p38 MAPK signalling pathway.
Fang K; Hu C; Zhang X; Hou Y; Gao D; Guo Z; Li L
Carcinogenesis; 2020 Sep; 41(9):1273-1281. PubMed ID: 31784750
[TBL] [Abstract][Full Text] [Related]
15. Homeobox B9 Promotes the Progression of Hepatocellular Carcinoma via TGF-
Bai L; Ge P; Zhang Y; Song Y; Xing R; Zhou D
Biomed Res Int; 2022; 2022():1080315. PubMed ID: 36158877
[TBL] [Abstract][Full Text] [Related]
16. CKAP2L, transcriptionally inhibited by FOXP3, promotes breast carcinogenesis through the AKT/mTOR pathway.
Chi F; Chen L; Jin X; He G; Liu Z; Han S
Exp Cell Res; 2022 Mar; 412(2):113035. PubMed ID: 35065924
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA LINC01503 promotes the progression of hepatocellular carcinoma via activating MAPK/ERK pathway.
Wang MR; Fang D; Di MP; Guan JL; Wang G; Liu L; Sheng JQ; Tian DA; Li PY
Int J Med Sci; 2020; 17(9):1224-1234. PubMed ID: 32547318
[No Abstract] [Full Text] [Related]
18. Elevated Expression of RIOK1 Is Correlated with Breast Cancer Hormone Receptor Status and Promotes Cancer Progression.
Huang Z; Li X; Xie T; Gu C; Ni K; Yin Q; Cao X; Zhang C
Cancer Res Treat; 2020 Oct; 52(4):1067-1083. PubMed ID: 32599985
[TBL] [Abstract][Full Text] [Related]
19. Oncoprotein HBXIP promotes tumorigenesis through MAPK/ERK pathway activation in non-small cell lung cancer.
Zhang J; Sun B; Ruan X; Hou X; Zhi J; Meng X; Zheng X; Gao M
Cancer Biol Med; 2021 Feb; 18(1):105-119. PubMed ID: 33628588
[TBL] [Abstract][Full Text] [Related]
20. LncRNA UCA1 promotes development of gastric cancer via the miR-145/MYO6 axis.
Yang A; Liu X; Liu P; Feng Y; Liu H; Gao S; Huo L; Han X; Wang J; Kong W
Cell Mol Biol Lett; 2021 Jul; 26(1):33. PubMed ID: 34238213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]